Flex Pharma Presenting at Upcoming Investor Conferences in September 2016
September 01 2016 - 8:30AM
Business Wire
Click to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS) today announced that it will
present a corporate overview at the following upcoming investor
conferences in September:
- The BioCentury NewsMakers Conference on
September 9, 2016 at 11:30 a.m. in New York, NY;
- The Rodman & Renshaw 18th Annual
Global Investment Conference on September 13, 2016 at 9:35 a.m. in
New York, NY;
- The Mizuho Neuro-Focus Therapeutics
Conference on September 21, 2016 in Boston, MA.
A live webcast of Flex Pharma’s presentations at these
conferences may be accessed in the Investor section of the
Company’s website at www.flex-pharma.com. Please log on to the Flex
Pharma website approximately 15 minutes prior to the scheduled
webcast to ensure adequate time for any software downloads that may
be required. A replay of the webcast will be available on Flex
Pharma’s website for 2 weeks following each presentation.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for nocturnal leg cramps,
cramps and spasms associated with severe neuromuscular conditions
such as MS and ALS, and exercise-associated muscle cramps. Flex
Pharma was founded by National Academy of Science members Rod
MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D.,
recognized leaders in the fields of ion channels and neurobiology,
along with Chair and CEO Christoph Westphal, M.D., Ph.D.
Visit www.TeamHOTSHOT.com for updates and to learn more about
HOTSHOTTM, the Company’s consumer product which is scientifically
proven to prevent and treat muscle cramps.
HOTSHOTTM is a consumer product that is marketed to endurance
athletes for exercise-associated muscle cramps. HOTSHOTTM
complements the Company’s drug development business and is not
intended to diagnose, treat, cure or prevent any disease.
Follow Flex Pharma (@flexpharma) and HOTSHOTTM (@Team_HOTSHOT)
on Twitter
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160901005695/en/
Flex Pharma, Inc.Elizabeth Woo, 617-874-1829SVP, Investor
Relations & Corporate Communicationsirdept@flex-pharma.com
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Apr 2023 to Apr 2024